Mawer Investment Management Ltd. lowered its position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 14.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 635,838 shares of the medical instruments supplier’s stock after selling 107,065 shares during the quarter. Mawer Investment Management Ltd.’s holdings in DENTSPLY SIRONA were worth $31,531,000 at the end of the most recent quarter.
A number of other hedge funds have also recently modified their holdings of XRAY. Anchor Capital Advisors LLC raised its stake in DENTSPLY SIRONA by 23.5% during the first quarter. Anchor Capital Advisors LLC now owns 463,766 shares of the medical instruments supplier’s stock worth $22,998,000 after acquiring an additional 88,353 shares during the period. Magnus Financial Group LLC acquired a new stake in DENTSPLY SIRONA during the first quarter worth about $224,000. Parametric Portfolio Associates LLC raised its stake in DENTSPLY SIRONA by 3.1% during the first quarter. Parametric Portfolio Associates LLC now owns 992,095 shares of the medical instruments supplier’s stock worth $49,198,000 after acquiring an additional 29,541 shares during the period. First Trust Advisors LP raised its stake in DENTSPLY SIRONA by 203.9% during the first quarter. First Trust Advisors LP now owns 91,083 shares of the medical instruments supplier’s stock worth $4,517,000 after acquiring an additional 61,111 shares during the period. Finally, Rational Advisors LLC raised its stake in DENTSPLY SIRONA by 2,536.6% during the first quarter. Rational Advisors LLC now owns 5,616 shares of the medical instruments supplier’s stock worth $279,000 after acquiring an additional 5,403 shares during the period. Hedge funds and other institutional investors own 91.69% of the company’s stock.
In related news, Director Eric Brandt sold 9,160 shares of the stock in a transaction that occurred on Friday, May 3rd. The shares were sold at an average price of $53.45, for a total transaction of $489,602.00. Following the completion of the sale, the director now directly owns 26,003 shares of the company’s stock, valued at $1,389,860.35. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Daniel P. Key bought 3,697 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The shares were acquired at an average cost of $54.68 per share, with a total value of $202,151.96. Following the completion of the purchase, the senior vice president now owns 9,024 shares of the company’s stock, valued at $493,432.32. The disclosure for this purchase can be found here. Insiders sold 123,922 shares of company stock valued at $6,790,905 over the last quarter. Insiders own 0.62% of the company’s stock.
Several research analysts have commented on XRAY shares. BidaskClub cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a research report on Friday. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $61.00 target price for the company in a research report on Saturday, May 11th. Barrington Research upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $63.00 target price for the company in a research report on Monday, May 6th. HC Wainwright restated a “neutral” rating and issued a $55.00 target price (up previously from $49.00) on shares of DENTSPLY SIRONA in a research report on Monday, May 6th. Finally, ValuEngine upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Eight equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $53.55.
Shares of DENTSPLY SIRONA stock traded up $0.01 on Monday, hitting $53.75. The company had a trading volume of 1,601,639 shares, compared to its average volume of 1,994,979. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.06 and a quick ratio of 1.35. The stock has a market capitalization of $12.58 billion, a PE ratio of 26.74, a price-to-earnings-growth ratio of 2.00 and a beta of 1.11. DENTSPLY SIRONA Inc has a 52 week low of $33.93 and a 52 week high of $55.88.
DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.10. The business had revenue of $946.20 million during the quarter, compared to analysts’ expectations of $925.13 million. DENTSPLY SIRONA had a negative net margin of 26.48% and a positive return on equity of 8.99%. The business’s revenue was down 1.0% on a year-over-year basis. During the same period last year, the firm posted $0.45 earnings per share. On average, analysts forecast that DENTSPLY SIRONA Inc will post 2.34 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be issued a $0.0875 dividend. The ex-dividend date of this dividend is Thursday, June 27th. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. This represents a $0.35 annualized dividend and a dividend yield of 0.65%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 17.41%.
ILLEGAL ACTIVITY WARNING: This article was first reported by Equities Focus and is owned by of Equities Focus. If you are accessing this article on another publication, it was illegally copied and republished in violation of international copyright and trademark law. The original version of this article can be accessed at https://www.equitiesfocus.com/2019/05/27/dentsply-sirona-inc-xray-holdings-reduced-by-mawer-investment-management-ltd.html.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.